Evidence map›Paper›PMID 41249056›Full record

ArticleRenal failure2025

Associations of hypoglycemic medications, cordycepin and vaccination with clinical outcomes in diabetic kidney disease patients with COVID-19.

Yanan Liu, Xuejie Yao, Jianhang Xu, Richard Hubbard, Allen G Ross, Muhammad J A Shiddiky, Ming Zhan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yanan LiuSchool of Medicine, Ningbo University, Ningbo, China.
Xuejie YaoDepartment of Medicine, The First Affiliated Hospital, Ningbo University, Ningbo, China.
Jianhang XuSchool of Medicine, Zhejiang University, Hangzhou, China.
Richard HubbardSchool of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.
Allen G RossRural Health Research Institute, Charles Sturt University, Orange, Australia.
Muhammad J A ShiddikyRural Health Research Institute, Charles Sturt University, Orange, Australia.
Ming ZhanDepartment of Medicine, The First Affiliated Hospital, Ningbo University, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The associations between hypoglycemic medications, cordycepin, COVID-19 vaccination, and clinical outcomes of SARS-CoV-2 infection were examined in a retrospective cohort of patients with diabetic kidney disease (DKD) in Ningbo, China, between December 2022 and June 2023. Acute COVID-19 outcomes included fever, pneumonia, hospitalization, and prolonged symptoms. Short-term DKD outcomes at three months post-infection included a serum creatinine increase ≥ 30%, an estimated glomerular filtration rate (eGFR) decrease ≥ 10 mL/min/1.73 m

Indexed as

COVID-19COVID-19 VaccinesDeoxyadenosinesDiabetic NephropathiesHypoglycemic AgentsAgedChinaCreatinineDipeptidyl-Peptidase IV InhibitorsFemaleGlomerular Filtration RateGlycated HemoglobinHumansMaleMetforminMiddle AgedcordycepinCOVID-19 VaccinesCreatinineDeoxyadenosinesDipeptidyl-Peptidase IV InhibitorsGlycated HemoglobinHypoglycemic AgentsMetforminSodium-Glucose Transporter 2 InhibitorscordycepinCOVID-19diabetic kidney diseasehypoglycemic drugsvaccination

Identifiers

PMID41249056
PMCPMC12624947

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.